About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
T
Updates in ALL: Incorporating Immunotherapy in Frontline Management
By
Talha Badar
8 Videos
124 views
September 16, 2024
0 Comments
Login to view comments.
Click here to Login
Featured Video
37:21
Amgen Sponsorship
New Approval for Frontline Consolidation in Patients with CD19-posit…
Feat.
J. Mccloskey
Featured Video
16:26
Incyte
Effects of a Treatment Option on Hematocrit Control and Spleen Volum…
Feat.
C. Harrison
Related Content
AUTOPLAY
ON
21:05
Louisville Hematology Highlights
Why Are Our Hematopoietic Stem Cells in the Bone Marrow?
Feat.
R. Gale
22:37
Insights from 2023 ASH Annual Meeting
AML and MDS Highlights & Key Takeaways
Feat.
T. Badar
08:47
Sarah Tasian
Recent Updates on Blinatumomab in ALL: FDA Approval in 1L and Incorp…
09:51
i3 Health
MRD Testing in Leukemias: When Negativity Is a Positive Thing
Feat.
N. S. Raje
24:44
Indy Hematology Review
State of the Art in 2024: Emerging Therapies in Hematologic Malignan…
Feat.
R. Birhiray
16:28
Fred Hutchinson Cancer Center
Blinatumomab for Ph- ALL in First MRD-Negative Remission: E1910 and …
Feat.
R. Cassaday
13:51
Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course
ALL in Adults: Overview and Recent Advances
Feat.
R. Cassaday
14:39
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
Immunotherapies in Acute Leukemias: 2024 Update
Feat.
C. Lai
28:33
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
The Truth About Current Consensus Statements on Hematopoietic Cell T…
Feat.
R. Gale
13:26
Steven Pavletic
Chronic GvHD: Main Complications After ASCT
09:42
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Post-Transplant Cyclophosphamide-Based Gv…
Feat.
M. Al Malki
31:41
MyCancerHaven
Treating Adults With Newly Diagnosed ALL
Feat.
R. Vij,
A. Patel
22:30
Rush University Medical Center
Selection and Sequencing of Chronic GVHD Therapy
Feat.
S. Kosuri
20:49
Salman Fazal
Blinatumomab in First-Line ALL - Safety, Efficacy, and Experience
20:28
Insights from 2023 ASH Annual Meeting
Clinically-Relevant Updates in ALL in Adults
Feat.
R. Cassaday
28:07
Indy Hematology Review
Controversies and Recommendations for the Treatment of ALL and Lymph…
Feat.
W. Stock
18:01
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Incorporation of Targeted and Immunotherapies in ALL
Feat.
H. Kantarjian
19:52
SOHO Brazil 2024
How Are Targeted Therapies Redefining the Treatment Paradigm in ALL …
Feat.
J. Burger
37:03
SOHO Highlights: State of the Art and Next Questions
State of the Art and Next Questions: ALL
Feat.
E. Jabbour
20:38
Ernst Holler
GVHD: Importance of Early Detection and Management